Sato, S.; Iino, C.; Furusawa, K.; Yoshida, K.; Chinda, D.; Sawada, K.; Mikami, T.; Nakaji, S.; Fukuda, S.; Sakuraba, H.
Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population. J. Clin. Med. 2025, 14, 2013.
https://doi.org/10.3390/jcm14062013
AMA Style
Sato S, Iino C, Furusawa K, Yoshida K, Chinda D, Sawada K, Mikami T, Nakaji S, Fukuda S, Sakuraba H.
Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population. Journal of Clinical Medicine. 2025; 14(6):2013.
https://doi.org/10.3390/jcm14062013
Chicago/Turabian Style
Sato, Satoshi, Chikara Iino, Keisuke Furusawa, Kenta Yoshida, Daisuke Chinda, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Shinsaku Fukuda, and Hirotake Sakuraba.
2025. "Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population" Journal of Clinical Medicine 14, no. 6: 2013.
https://doi.org/10.3390/jcm14062013
APA Style
Sato, S., Iino, C., Furusawa, K., Yoshida, K., Chinda, D., Sawada, K., Mikami, T., Nakaji, S., Fukuda, S., & Sakuraba, H.
(2025). Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population. Journal of Clinical Medicine, 14(6), 2013.
https://doi.org/10.3390/jcm14062013
